Basilea Pharmaceutica Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Basilea Pharmaceutica Limited with three other
miscellaneous service companies in Europe:
sales of 51.01 million Euro [US$60.29 million]
of which 105%
Innate Pharma S.A.
(56.16 million Euro [US$66.38 million]
of which 100%
was Licensing Revenue), and
based in Germany
(49.74 million Euro [US$58.80 million]
of which 99%
was Partnered Discovery).
Basilea Pharmaceutica Limited reported sales of 65.04 million Swiss Francs (US$66.71 million)
December of 2016.
increase of 25.9%
versus 2015, when the company's sales were 51.65 million Swiss Francs.
This was the third consecutive year of growth at Basilea Pharmaceutica Limited.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Basilea Pharmaceutica Limited had sales
of 66.70 million Swiss Francs.